Cannabis Law Report

FEBRUARY 23, 2022

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research.

Pharmaceutical 52

Pharmaceutical Research and Development Extraction Cannabinoids 52

Cannabis Law Report

MARCH 9, 2022

Pharmaceuticals & Medical Devices. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Enjoy competitive salary package, and employment benefits.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

SEPTEMBER 3, 2019

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

SEPTEMBER 8, 2021

Epsilon’s Southport Facility is the largest cannabis extraction facility in the Southern Hemisphere with TGA and EU GMP capability. THC Pharma’s GMP Southport facility is a 10,000 square foot purpose-built botanicals extraction facility capable of extraction of raw plant material and downstream purification and isolation processing.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

OCTOBER 12, 2021

d/b/a Venom Extracts (“ Venom Extracts “) which transformed the Company into a multi-state operator and substantially enhanced its revenue, capabilities and reach. Jake is the founder of Venom Extracts, one of the industry’s premier award-winning cannabis concentrate brands. I’m humbled and excited to take on this challenge.

Extraction 52

Extraction Business Hash Events 52

Cannabis Law Report

AUGUST 19, 2019

The recent trend towards decriminalization of cannabis in other countries suggests they may be right, but in the meantime, a proliferation of products containing extracts from cannabis plants are appearing in UK stores. This Client Alert sets out the current rules regarding the regulation of cannabis products and medicinal cannabis in the UK.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

JANUARY 9, 2019

Armed with their mission, in June 2018, Phoenix merged many of its partnership organisations together under the name Phoenix Life Sciences International Limited, placing expert botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors together under one roof.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85